페이지 1 ...에서 17 결과
This application includes as part of its disclosure a biological sequence listing which is being concurrently submitted through EFS-Web. Said biological sequence listing is contained in a file named "56256o1204.txt" which was created on Dec. 15, 2016, and has a size of 238,677 bytes, and is hereby
The sequence listing in the file named "67858o702005.txt" having a size of 238,525 bytes that was created Nov. 25, 2008 is hereby incorporated by reference in its entirety.
BACKGROUND OF THE INVENTION
Field of the Invention
This invention is an extension of Applicants' prior invention disclosed in
This application claims priority to U.S. Ser. No. 12/153,612 filed May 21, 2008, U.S. Ser. No. 12/153,611 filed May 21, 2008, U.S. Ser. No. 12/124,723 filed May 21, 2008, provisional patent application No. 60/924,550, filed May 21, 2007, and provisional patent application No. 60/924,551, filed May
BACKGROUND OF THE INVENTION
1. Field of the Invention
This invention is an extension of Applicants' prior invention disclosed in the above-referenced patent applications relating to novel anti-IL-6 antibodies and novel therapies and therapeutic protocols using anti-IL-6 antibodies, preferably those
BACKGROUND OF THE INVENTION
Field of the Invention
This invention is an extension of Applicants' prior invention disclosed in the above-referenced patent applications relating to novel anti-IL-6 antibodies and novel therapies and therapeutic protocols using anti-IL-6 antibodies, preferably those
BACKGROUND OF THE INVENTION
Field of the Invention
This invention is an extension of Applicants' prior invention disclosed in the above-referenced patent applications relating to novel anti-IL-6 antibodies and novel therapies and therapeutic protocols using anti-IL-6 antibodies, preferably those
FIELD OF THE INVENTION
This invention relates to novel compounds and their use to treat and prevent disorders and diseases associated with the RyR receptors that regulate calcium channel functioning in cells. More particularly, the invention discloses compounds that are related to
FIELD OF THE INVENTION
This invention relates to novel compounds and their use to treat and prevent disorders and diseases associated with the RyR receptors that regulate calcium channel functioning in cells. More particularly, the invention discloses compounds that are related to
SEQUENCE LISTING
The sequence listing in the file named "43257o2014.txt" having a size of 335,872 bytes that was created Mar. 30, 2015 is hereby incorporated by reference in its entirety.
BACKGROUND OF THE INVENTION
Field of the Invention
This invention is an extension of Applicants' prior invention
The sequence listing in the file named "67858o707005.txt" having a size of 332,004 bytes that was created Nov. 23, 2009 is hereby incorporated by reference in its entirety.
BACKGROUND OF THE INVENTION
Field of the Invention
This invention is an extension of Applicants' prior invention disclosed in
The sequence listing in the file named "43272o1806.txt" having a size of 331,953 bytes that was created May 29, 2015 is hereby incorporated by reference in its entirety.
BACKGROUND
1. Field of the Art
This invention is an extension of Applicants' prior invention disclosed in the above-referenced
The sequence listing in the file name "56256o1808" having a size of 43,704 bytes that was created Mar. 22, 2018 is hereby incorporated by reference in its entirety.
BACKGROUND OF THE INVENTION
Field of the Invention
This invention is an extension of Applicants' prior invention disclosed in the
The sequence listing in the file named "43272ol1805.txt" having a size of 341,671 bytes that was created Apr. 3, 2014 is hereby incorporated by reference in its entirety.
BACKGROUND
1. Field of the Art
This invention is an extension of Applicants' prior invention disclosed in the above-referenced
BACKGROUND
1. Field of the Art
This invention is an extension of Applicants' prior invention disclosed in the above-referenced patent applications relating to novel anti-IL-6 antibodies, novel therapies and therapeutic protocols utilizing anti-IL-6 antibodies, and pharmaceutical formulations
BACKGROUND OF THE INVENTION
Field of the Invention
This invention is an extension of Applicants' prior invention disclosed in the above-referenced patent applications relating to novel anti-IL-6 antibodies, novel therapies and therapeutic protocols utilizing anti-IL-6 antibodies, and pharmaceutical